Home > Boards > US Listed > Biotechs >

MediciNova, Inc. (MNOV)

MNOV RSS Feed
Add MNOV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/28/2020 7:33:50 PM - Followers: 18 - Board type: Free - Posts Today: 0

http://www.medicinova.com/

http://finance.yahoo.com/q/ks?s=MNOV

MediciNova, Inc., a biopharmaceutical company, engages in the acquisition and development of small molecule therapeutics worldwide. The company's clinical products under development include MN-001 for the treatment of bronchial asthma, which is in Phase III clinical program; MN-221 for the treatment of status asthmaticus, which is in Phase II clinical trial; MN-166 for the treatment of multiple sclerosis that is in a two year randomized, double-blind, placebo-controlled multi-center Phase II clinical trial; and MN-001 for the treatment of interstitial cystitis, which completed a Phase II/III clinical trial. It also develops MN-029 for the treatment of solid tumors, which completed Phase I clinical trial; MN-305 for the treatment of generalized anxiety disorder, which completed a Phase II/III clinical trial; MN-305 for the treatment of insomnia that is in Phase II clinical trial; and MN-221 for the treatment of preterm labor, which is in Phase Ib clinical study. In addition, the company develops MN-246 for the treatment of urinary incontinence, which completed a double-blind, randomized, placebo-controlled, single escalating dose Phase I clinical trial; MN-447 for the treatment of thrombotic disorders, which is in preclinical development stage; and MN-462 for the treatment of thrombotic disorders, which is in preclinical development stage. MediciNova, Inc. has strategic alliances with Kissei Pharmaceutical Co, Ltd.; Kyorin Pharmaceutical; Mitsubishi Pharma Corporation; Meiji Seika Kaisha, Ltd.; and Angiogene Pharmaceuticals, Ltd. The company was founded in 2000 and is headquartered in San Diego, California.


MNOV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MNOV News: Annual Report (10-k) 02/19/2021 06:04:32 AM
MNOV News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 02/12/2021 06:13:06 AM
MNOV News: Statement of Changes in Beneficial Ownership (4) 02/04/2021 04:18:24 PM
MNOV News: Statement of Changes in Beneficial Ownership (4) 02/04/2021 04:18:20 PM
MNOV News: Statement of Changes in Beneficial Ownership (4) 02/04/2021 04:18:17 PM
PostSubject
#421   https://www.marketbeat.com/stocks/NASDAQ/MNOV/ Raffis 09/28/20 07:33:50 PM
#420   Yale researchers will begin a clinical trial at Raffis 09/28/20 06:51:40 PM
#419   Company received funding for pipeline development from confident Raffis 09/25/20 09:49:57 AM
#418   Earnings looking great: Raffis 09/25/20 09:04:52 AM
#417   About MN-001 Positive Phase 2 Results Raffis 09/24/20 05:07:19 PM
#416   Phase II Study – MN-221-CL-004 Raffis 09/24/20 04:57:56 PM
#415   https://tickeron.com/ticker/MNOV/ Raffis 09/24/20 04:07:15 PM
#414   VERIFIED DATA: https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Ibudilast-Cognitive-Vit Raffis 09/24/20 03:58:48 PM
#413   https://rsds.org/wp-content/uploads/2015/02/Rolan_Ibudilast_Review.pdf Raffis 09/24/20 03:54:10 PM
#412   “Ibudilast is a relatively non-selective phosphodiesterase inhibitor which Raffis 09/24/20 03:53:46 PM
#411   FDA Gives OK to Medicinova’s Phase 3 Clinical Raffis 09/24/20 03:47:06 PM
#410   FDA Approves Pivotal Phase 2b/3 Trial for Ibudilast Raffis 09/24/20 03:46:08 PM
#409   FDA accepted MediciNova's IND for MN-166 (ibudilast) for Raffis 09/24/20 03:41:37 PM
#408   To see whether mice develop an illness similar Raffis 09/24/20 03:33:30 PM
#407   Medicinova’s resources are jointly helping BioComo to produce Raffis 09/24/20 02:55:19 PM
#406   Spread company news on other boards. Raffis 09/24/20 02:47:46 PM
#405   Clinical pipeline development progress image & link: Raffis 09/24/20 02:41:42 PM
#404   MediciNova said administering MN-166 with cancer medication oxaliplatin Raffis 09/24/20 02:32:51 PM
#403   BC-PIV, an innovative non-transmissible viral vector co-developed by Raffis 09/24/20 02:31:03 PM
#402   Great PR’s and this plummets 20%. It couldn’t Biggiee 09/24/20 11:29:15 AM
#401   * * $MNOV Video Chart 09-23-2020 * * ClayTrader 09/23/20 04:43:04 PM
#400   Huge news today covid inhaler Rekaewt 09/23/20 10:23:45 AM
#399   Possible 9-10 dollars with this news. dinogreeves 08/06/20 07:55:57 AM
#398   * * $MNOV Video Chart 07-27-2020 * * ClayTrader 07/27/20 04:32:20 PM
#397   Yeah, sometimes it takes a bit longer than microcapbiotech 07/27/20 04:07:14 PM
#396   wow MNOV [SMART MONEY] 07/27/20 12:36:08 PM
#395   up 15.9 % today edwardport 04/13/20 07:17:09 PM
#394   up 15.9 % today edwardport 04/13/20 07:17:08 PM
#393   MNOV appears to have great doctors working edwardport 04/12/20 08:03:49 PM
#392   UP A GOOD BIT, BUT STILL UNDERVALUED AT microcapbiotech 05/10/19 03:18:37 PM
#391   A VERY Bright and Profitable future for MNOV, microcapbiotech 11/01/18 11:18:59 AM
#390   UP TODAY - STILL CHEAP - BUY NOW microcapbiotech 10/30/18 06:22:30 PM
#389   I CAN NOT BELIEVE - almost a year, microcapbiotech 09/26/18 02:32:11 PM
#388   Great FDA news today, tried to tell everyone microcapbiotech 09/26/18 02:18:04 PM
#387   PEOPLE / INVESTORS - price has gone up microcapbiotech 09/25/18 04:30:37 PM
#386   like I said... and it's going to go microcapbiotech 07/06/18 11:18:53 AM
#385   Like a bird tweeting, cheap, cheap, cheap. microcapbiotech 06/22/18 02:52:43 AM
#384   three words, BUY NOW HOLD microcapbiotech 06/15/18 07:59:20 PM
#383   MediciNova Announces Positive Top-Line Results from the Clinical Minding 12/07/17 09:22:57 PM
#382   MNOV bullish 6.54 stocktrademan 09/20/16 11:26:51 AM
#381   Thank you George. someconcerns 02/08/16 08:43:47 PM
#380   Two things of interest if you follow this Minding 02/03/16 01:29:22 PM
#379   $MNOV recent news/filings stocktrademan 12/14/15 11:39:14 AM
#378   S3 filed 12/1/2015: http://www.sec.gov/Archives/edgar/data/1226616/0001193125153 Minding 12/01/15 10:39:30 AM
#377   A thought from my friend Carl: Minding 11/19/15 03:42:06 PM
#376   Just need to be patient. We will get someconcerns 10/27/15 09:21:09 PM
#375   One view, technical for the most part. Minding 10/22/15 08:06:00 AM
#374   Good, I'm glad you have enough patience for someconcerns 09/11/15 01:33:14 PM
#373   I am a bit surprised at the lack Ebuilder 09/11/15 01:26:15 PM
#372   This is true - that it has not someconcerns 09/10/15 12:54:31 PM
PostSubject
Consent Preferences